Shiga Toxins: An Update on Host Factors and Biomedical Applications
Overview
Authors
Affiliations
Shiga toxins (Stxs) are classic bacterial toxins and major virulence factors of toxigenic and enterohemorrhagic (EHEC). These toxins recognize a glycosphingolipid globotriaosylceramide (Gb3/CD77) as their receptor and inhibit protein synthesis in cells by cleaving 28S ribosomal RNA. They are the major cause of life-threatening complications such as hemolytic uremic syndrome (HUS), associated with severe cases of EHEC infection, which is the leading cause of acute kidney injury in children. The threat of Stxs is exacerbated by the lack of toxin inhibitors and effective treatment for HUS. Here, we briefly summarize the Stx structure, subtypes, in vitro and in vivo models, Gb3 expression and HUS, and then introduce recent studies using CRISPR-Cas9-mediated genome-wide screens to identify the host cell factors required for Stx action. We also summarize the latest progress in utilizing and engineering Stx components for biomedical applications.
Popoff M Toxins (Basel). 2024; 16(4).
PMID: 38668607 PMC: 11054074. DOI: 10.3390/toxins16040182.
Gaining New Insights into Fundamental Biological Pathways by Bacterial Toxin-Based Genetic Screens.
Tian S, Zhou N Bioengineering (Basel). 2023; 10(8).
PMID: 37627769 PMC: 10451959. DOI: 10.3390/bioengineering10080884.
AB Toxins as High-Affinity Ligands for Cell Targeting in Cancer Therapy.
Marquez-Lopez A, Fanarraga M Int J Mol Sci. 2023; 24(13).
PMID: 37446406 PMC: 10343017. DOI: 10.3390/ijms241311227.
Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy.
Danielewicz N, Rosato F, Tomisch J, Graber J, Wiltschi B, Striedner G ACS Omega. 2023; 8(17):15406-15421.
PMID: 37151527 PMC: 10157870. DOI: 10.1021/acsomega.3c00667.
Advanced Situation with Recombinant Toxins: Diversity, Production and Application Purposes.
Efremenko E, Aslanli A, Lyagin I Int J Mol Sci. 2023; 24(5).
PMID: 36902061 PMC: 10003545. DOI: 10.3390/ijms24054630.